Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Clinical trial NCT07365462 · RECRUITING
Trial details
- NCT number
- NCT07365462
- Sponsor
- Neurocrine Biosciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-06
- Primary completion
- 2027-02-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.